Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
22/12/2025
New York gold futures broke through $4440 per ounce, rising 1.21% intraday.
Latest
3 m ago
The US building price index increased by 0.22% on a weekly basis, rising for 4 consecutive weeks.
5 m ago
The main construction of the first phase of the Bailong Nuclear Power Plant has begun.
5 m ago
China Iron and Steel Association: China Minmetals Group should include domestic indexes in pricing options during negotiations with the four major mining companies.
5 m ago
AstraZeneca: Ceralasertib can be used to treat advanced non-small cell lung cancer. The overall tolerability of the combination therapy of Ceralasertib and Imfinzi is good. The safety profile is consistent with what is known for each drug, and no new safety concerns have been identified.
6 m ago
AstraZeneca: Ceralasertib can be used to treat advanced non-small cell lung cancer. The combination therapy of Ceralasertib and Imfinzi has overall good tolerability.
See all latest